Shionogi & Co logo

4507 - Shionogi & Co Share Price

¥6201 -85.0  -1.4%

Last Trade - 7:00am

Sector
Healthcare
Size
Large Cap
Market Cap £13.83bn
Enterprise Value £11.08bn
Revenue £2.47bn
Position in Universe 65th / 3867
Bullish
Bearish
Unlock 4507 Revenue
Momentum
Relative Strength (%)
1m -2.24%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
273,991 309,973 338,890 344,667 363,721 333,371 337,139 336,679 +4.0%
+4.2 +64.6 +20.9 +29.3 +33.0 -16.7 -3.73 -1.33
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Shionogi & Co Ltd revenues totaled Y333.37B. Net income applicable to common stockholders totaled to Y122.19B. Results are not comparable due to GAAP change.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4507
Graphical History

Revenue

4507 Revenue Unlock 4507 Revenue

Net Income

4507 Net Income Unlock 4507 Revenue

Normalised EPS

4507 Normalised EPS Unlock 4507 Revenue

PE Ratio Range

4507 PE Ratio Range Unlock 4507 Revenue

Dividend Yield Range

4507 Dividend Yield Range Unlock 4507 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4507 EPS Forecasts Unlock 4507 Revenue
Profile Summary

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.

Directors
Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated June 5, 1919
Public Since May 16, 1949
No. of Shareholders: 32,661
No. of Employees: 5,233
Sector Healthcare
Industry Pharmaceuticals
Index Nikkei 225 , Nikkei 300 ,
Exchange Tokyo Stock Exchange
Shares in Issue 301,497,623
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4507 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4507
Upcoming Events for 4507
Monday 27th July, 2020 Estimate
Q1 2021 Shionogi & Co Ltd Earnings Release
Tuesday 29th September, 2020
Dividend For 4507.T - 53.0000 JPY
Wednesday 28th October, 2020 Estimate
Q2 2021 Shionogi & Co Ltd Earnings Release
Frequently Asked Questions for Shionogi & Co
What is the Shionogi & Co share price?

As of 7:00am, shares in Shionogi & Co are trading at ¥6201, giving the company a market capitalisation of £13.83bn. This share price information is delayed by 15 minutes.

How has the Shionogi & Co share price performed this year?

Shares in Shionogi & Co are currently trading at ¥6201 and the price has moved by -0.59% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Shionogi & Co price has moved by -4.99% over the past year.

What are the analyst and broker recommendations for Shionogi & Co?

Of the analysts with advisory recommendations for Shionogi & Co, there are there are currently 2 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Shionogi & Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Shionogi & Co next release its financial results?

Shionogi & Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Shionogi & Co dividend yield?

The Shionogi & Co dividend yield is 1.66% based on the trailing twelve month period.

Does Shionogi & Co pay a dividend?

Last year, Shionogi & Co paid a total dividend of 0.103k, and it currently has a trailing dividend yield of 1.66%. Looking ahead, shares in Shionogi & Co are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01.

When does Shionogi & Co next pay dividends?

Shionogi & Co are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01. The historic dividend yield on Shionogi & Co shares is currently 1.66%.

How do I buy Shionogi & Co shares?

To buy shares in Shionogi & Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Shionogi & Co?

Shares in Shionogi & Co are currently trading at ¥6201, giving the company a market capitalisation of £13.83bn.

Where are Shionogi & Co shares listed? Where are Shionogi & Co shares listed?

Here are the trading details for Shionogi & Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4507
What kind of share is Shionogi & Co?

Based on an overall assessment of its quality, value and momentum, Shionogi & Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Shionogi & Co share price forecast 2020?

Shares in Shionogi & Co are currently priced at ¥6201. At that level they are trading at 10.67% discount to the analyst consensus target price of 0.00.

Analysts covering Shionogi & Co currently have a consensus Earnings Per Share (EPS) forecast of 376.249 for the next financial year.

How can I tell whether the Shionogi & Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shionogi & Co. Over the past six months, the relative strength of its shares against the market has been -4.56%. At the current price of ¥6201, shares in Shionogi & Co are trading at 0.91% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Shionogi & Co PE Ratio?

The Shionogi & Co PE ratio based on its reported earnings over the past 12 months is 15.87. The shares are currently trading at ¥6201.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Shionogi & Co?

Shionogi & Co's management team is headed by:

Motozo Shiono - CHM
Isao Teshirogi - PRE
Teppei Mogi - IND
Yoshiaki Kamoya - SEO
Takuko Sawada - VPR
Ryuichi Kume - SEO
Koji Hanasaki - SEO
John Keller - SEO
Kazuhiro Hatanaka - SEO
Miyuki Hiura - EXO
Toshinobu Iwasaki - SEO
Keiichi Ando - IND
Hiroshi Ozaki - IND
Who are the major shareholders of Shionogi & Co?

Here are the top five shareholders of Shionogi & Co based on the size of their shareholding:

Nomura Asset Management Co., Ltd. Investment Advisor
Percentage owned: 6.51% (20.3m shares)
Sumitomo Life Insurance Co. Insurance Company
Percentage owned: 5.97% (18.6m shares)
Mitsubishi UFJ Trust and Banking Corporation Bank and Trust
Percentage owned: 3.52% (11.0m shares)
Nomura Nikkei 225 ETF Mutual Fund
Percentage owned: 3.17% (9.87m shares)
SMBC Trust Bank (Trust) Corporation
Percentage owned: 3.04% (9.49m shares)
Similar to 4507
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.